| Literature DB >> 23508237 |
Laleh Nikfarjam1, Parvaneh Farzaneh.
Abstract
One of the main problems in cell culture is mycoplasma infection. It can extensively affect cell physiology and metabolism. As the applications of cell culture increase in research, industrial production and cell therapy, more concerns about mycoplasma contamination and detection will arise. This review will provide valuable information about: 1. the ways in which cells are contaminated and the frequency and source of mycoplasma species in cell culture; 2. the ways to prevent mycoplasma contamination in cell culture; 3. the importance of mycoplasma tests in cell culture; 4. different methods to identify mycoplasma contamination; 5. the consequences of mycoplasma contamination in cell culture and 6. available methods to eliminate mycoplasma contamination. Awareness about the sources of mycoplasma and pursuing aseptic techniques in cell culture along with reliable detection methods of mycoplasma contamination can provide an appropriate situation to prevent mycoplasma contamination in cell culture.Entities:
Keywords: Cell Culture; Elimination; Mycoplasma; Prevention
Year: 2011 PMID: 23508237 PMCID: PMC3584481
Source DB: PubMed Journal: Cell J ISSN: 2228-5806 Impact factor: 2.479
Effects of mycoplasma contaminations on cell cultures
| Increased sensitivity to apoptosis |
|---|
| Chromosomal aberrations |
| Change of gene expression patterns |
| Changes in cell membrane antigenicity |
| Inhibition of cell growth |
| DNA fragmentation due to mycoplasma nucleases |
| Compromised production of viruses |
| Inhibition of cell metabolism |
| Reduction of transfection efficiencies |
| Cell death |
Effective anti-mycoplasma antibiotics
| Brand name | Generic name | Antibiotic category |
|---|---|---|
| BM-Cyclin | Tiamulin (BM-Cyclin 1) | Macrolide |
| Minocycline (BM-Cyclin 2) | Tetracycline | |
| Ciprobay | Ciprofloxacin | Quinolone |
| Baytril | Enrofloxacin | Quinolone |
| Zagam | Sparfloxacin | Quinolone |
| MRA | unknown | Quinolone |
| Plasmocin | unknown | Tetracycline? |
| unknown | Quinolone | |
Potential sources of cell culture contamination
| Human | Foot | 100-1000 organisms/cm2 |
|---|---|---|
| Scalp | 106 organisms/cm2 | |
| Forehead | 105 organisms/cm2 | |
| Sneeze | 104-105 organisms | |
| Saliva | 107 organisms/ml | |
| Sterile clothing | After 6 hours | 1-6 organisms/cm2 |
| Air | Outdoor | 100-500 organisms/m3 |
| Indoor | 500-2000 organisms/m3 | |
Major mycoplasma species found in cell cultures and their likely sources
| Species | Source of origin | 1958- 1972 | 1966- 1982 | 1973- 1979 | 1988 | 2002 |
|---|---|---|---|---|---|---|
| Mycoplasma | Swine | 15.9% | 30.1% | 2.0% | 26% | 10-40% |
| Mycoplasma | Bovine | 21.4% | 24.8% | 2.3% | 21% | 20-30% |
| Acholeplasma | Bovine | 8.5% | 9.7% | 20.0% | 5% | 5-20% |
| Mycoplasma | Swine | 6.1% | 2.4% | 1.8% | --- | 10-20% |
| Mycoplasma | Human | --- | <1% | 16.2% | --- | --- |
| Mycoplasma | Human | 38.8% | 34.4% | 41.3% | 34% | 20-40% |
| Mycoplasma | Human | 0.36% | 4.1% | 1.3% | 13% | 10-20% |
| Unidentified | 1.2% | 15.1% | ||||
Antibiotic resistance of mycoplasma from infected cell cultures
| Antibiotic | Resistance |
|---|---|
| Chloramphenicol | 30% |
| Chlortetracycline | 11% |
| Ciprofloxacin | 15% |
| Erythromycin | 98% |
| Gentamicin | 80% |
| Kanamycin | 73% |
| Lincomycin | 28% |
| Neomycin | 86% |
| Spectinomycin | 14% |
| Streptomycin | 88% |
| Tetracycline | 14% |
| Tylosin | 21% |